Please provide your email address to receive an email when new articles are posted on . Patients who took vitamin D supplements had significantly longer a median treatment-free survival. Results ...

CEO Punit Dhillon highlighted significant progress with the clinical development of nimacimab, including the completion of patient enrollment for the CBeyond Phase IIa trial ahead of schedule. The ...